Search
Patexia Research
Case number 1:24-cv-00095

Advanced Accelerator Applications USA, Inc. et al v. Lantheus Medical Imaging, Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jul 2, 2024 41 PROPOSED ORDER Scheduling re Scheduling Conference,, [REVISED] by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Joyce, Alexandra) (Entered: 07/02/2024) (15)
Jun 28, 2024 40 NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions for Defendants Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc..(Joyce, Alexandra) (Entered: 06/28/2024) (2)
Jun 26, 2024 N/A Minute Entry for proceedings held before Judge Maryellen Noreika - Scheduling Telephone Conference held on 6/26/2024 as to proposed scheduling order ( 36 ). Paragraph 13 shall be amended to reflect that absent prior Court approval, the Court will not hear case dispositive motions. A Markman hearing is set for 5/9/2025 at 2:00 PM in Courtroom 4A, a 4-day Bench Trial is set for 10/27/2025, the pretrial conference is set for 10/21/2025 at 4:30 PM in Courtroom 4A, and the final proposed pretrial order is due by 10/14/2025. The parties shall file a revised proposed scheduling order within one week. (Court Reporter Dale Hawkins.) (mdb) (Entered: 06/26/2024) (0)
Jun 17, 2024 39 ORAL Order Setting Telephonic Scheduling Conference - IT IS HEREBY ORDERED that a telephonic Scheduling Conference is set for 6/26/2024 at 04:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 6/17/2024. (dlw) (Entered: 06/17/2024) (0)
Jun 12, 2024 38 REDACTED VERSION of 37 Answer to Counterclaim by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Joyce, Alexandra) (Entered: 06/12/2024) (18)
Jun 5, 2024 37 [SEALED] ANSWER to 31 Answer to Complaint,, Counterclaim, by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 06/05/2024) (0)
May 30, 2024 36 Letter to The Honorable Maryellen Noreika from Alexandra M. Joyce, Esq. regarding Proposed Scheduling Order (with one disputed provision). (Attachments: # 1 Proposed Scheduling Order)(Joyce, Alexandra) (Entered: 05/30/2024) (0)
May 8, 2024 N/A SO ORDERED re 35 STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendants Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc.'s Counterclaims to June 5, 2024 (Set/Reset Answer Deadlines: Advanced Accelerator Applications SA answer due 6/5/2024; Advanced Accelerator Applications USA, Inc. answer due 6/5/2024). ORDERED by Judge Maryellen Noreika on 5/8/2024. (dlw) (Entered: 05/08/2024) (0)
May 8, 2024 35 STIPULATION TO EXTEND TIME the Deadline for Plaintiffs to respond to Defendants Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc.'s Counterclaims to June 5, 2024 - filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Silver, Daniel) (Entered: 05/08/2024) (2)
May 8, 2024 34 REDACTED VERSION of 31 Answer to Complaint,, Counterclaim, by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Attachments: # 1 Exhibit 1)(Gaza, Anne) (Entered: 05/08/2024) (0)
May 2, 2024 33 ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. A bench trial will be set for 10/27/2025. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serves their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 5/2/2024. (dlw) (Entered: 05/02/2024) (0)
May 2, 2024 32 SO ORDERED re 30 Stipulation and Order Allowing the Parties to File Documents Under Seal. Signed by Judge Maryellen Noreika on 5/2/2024. (dlw) (Entered: 05/02/2024) (3)
May 1, 2024 31 [SEALED] ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc. (Attachments: # 1 Exhibit 1)(Gaza, Anne) Modified on 5/2/2024 (dlw). (Entered: 05/01/2024) (0)
May 1, 2024 30 STIPULATION and [Proposed] Order Allowing the Parties to File Documents Under Seal by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Wilson, Samantha) (Entered: 05/01/2024) (3)
Apr 30, 2024 29 NOTICE OF SERVICE of Plaintiffs' Initial Disclosures of Accused Products and Asserted Patents filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc..(Silver, Daniel) (Entered: 04/30/2024) (2)
Apr 29, 2024 N/A SO ORDERED re 28 STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise respond to the Complaint to May 1, 2024 (Set/Reset Answer Deadlines: Lantheus Holdings, Inc. answer due 5/1/2024; Lantheus Medical Imaging, Inc. answer due 5/1/2024). ORDERED by Judge Maryellen Noreika on 4/29/2024. (dlw) (Entered: 04/29/2024) (0)
Apr 29, 2024 28 STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise respond to the Complaint to May 1, 2024 - filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Wilson, Samantha) (Entered: 04/29/2024) (2)
Apr 26, 2024 N/A Pro Hac Vice Attorney Ryan E. Conkin for Lantheus Holdings, Inc., and Lantheus Medical Imaging, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 04/26/2024) (0)
Apr 25, 2024 N/A SO ORDERED re 26 MOTION for Pro Hac Vice Appearance of Attorney Ryan E. Conkin. Ordered by Judge Maryellen Noreika on 4/25/2024. (as) (Entered: 04/25/2024) (0)
Apr 25, 2024 27 Pro Hac Vice Fee - Credit Card Payment received for Ryan E. Conkin. ( re 26 MOTION for Pro Hac Vice Appearance of Attorney Ryan E. Conkin )( Payment of $ 50, receipt number ADEDC-4392873).(Mackrides, Daniel) (Entered: 04/25/2024) (0)
Apr 25, 2024 26 MOTION for Pro Hac Vice Appearance of Attorney Ryan E. Conkin - filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Mackrides, Daniel) (Entered: 04/25/2024) (4)
Apr 23, 2024 25 SO ORDERED, re 24 Stipulation Dismissing Without Prejudice Point Biopharma USA Inc. and Point Biopharma Global Inc. Party Point Biopharma Global Inc. and Point Biopharma USA Inc. terminated. Signed by Judge Maryellen Noreika on 4/23/2024. (mdb) (Entered: 04/23/2024) (5)
Apr 22, 2024 24 STIPULATION and [Proposed] Order Dismissing Without Prejudice Point Biopharma USA Inc. and Point Biopharma Global Inc. and Amending Caption to Reflect Same by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Silver, Daniel) (Entered: 04/22/2024) (5)
Apr 19, 2024 N/A SO ORDERED re 23 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 29, 2024 (Set/Reset Answer Deadlines: Lantheus Holdings, Inc. answer due 4/29/2024; Lantheus Medical Imaging, Inc. answer due 4/29/2024; Point Biopharma Global Inc. answer due 4/29/2024; Point Biopharma USA Inc. answer due 4/29/2024). ORDERED by Judge Maryellen Noreika on 4/19/2024. (dlw) (Entered: 04/19/2024) (0)
Apr 19, 2024 23 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 29, 2024 - filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) (Entered: 04/19/2024) (2)
Mar 19, 2024 N/A SO ORDERED, re 22 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 22, 2024. Set/Reset Answer Deadlines: Lantheus Holdings, Inc. answer due 4/22/2024; Lantheus Medical Imaging, Inc. answer due 4/22/2024; Point Biopharma Global Inc. answer due 4/22/2024; Point Biopharma USA Inc. answer due 4/22/2024. Ordered by Judge Maryellen Noreika on 3/19/2024. (as) (Entered: 03/19/2024) (0)
Mar 19, 2024 22 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 22, 2024 - filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) (Entered: 03/19/2024) (2)
Mar 15, 2024 N/A Pro Hac Vice Attorney Bruce M. Wexler for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 03/18/2024) (0)
Mar 15, 2024 N/A Pro Hac Vice Attorney David A. Chen for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 03/18/2024) (0)
Mar 15, 2024 N/A Pro Hac Vice Attorney Candace Polster for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 03/18/2024) (0)
Mar 15, 2024 N/A Pro Hac Vice Attorney Eric W. Dittmann for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 03/18/2024) (0)
Feb 23, 2024 N/A SO ORDERED re 20 MOTION for Pro Hac Vice Appearance of Attorney James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen and Candace M. Polster filed by Point Biopharma Global Inc., Point Biopharma USA Inc. ORDERED by Judge Maryellen Noreika on 2/23/2024. (dlw) (Entered: 02/23/2024) (0)
Feb 23, 2024 N/A Pro Hac Vice Attorney Jane M. Love for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 02/23/2024) (0)
Feb 23, 2024 21 Pro Hac Vice Fee - Credit Card Payment received for James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen, and Candace M. Polster. ( re 20 MOTION for Pro Hac Vice Appearance of Attorney James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen and Candace M. Polster )( Payment of $ 250, receipt number ADEDC-4345776).(Tigan, Jeremy) (Entered: 02/23/2024) (0)
Feb 23, 2024 20 MOTION for Pro Hac Vice Appearance of Attorney James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen and Candace M. Polster - filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) (Entered: 02/23/2024) (9)
Feb 22, 2024 19 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eli Lilly and Company for Point Biopharma Global Inc., Point Biopharma USA Inc. filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) (Entered: 02/22/2024) (3)
Feb 20, 2024 N/A SO ORDERED re 18 STIPULATION TO EXTEND TIME for Defendants POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer, or otherwise respond to the Complaint (D.I. 1) to March 21, 2024 (Set/Reset Answer Deadlines: Point Biopharma Global Inc. answer due 3/21/2024; Point Biopharma USA Inc. answer due 3/21/2024). ORDERED by Judge Maryellen Noreika on 2/20/2024. (dlw) (Entered: 02/20/2024) (0)
Feb 20, 2024 18 STIPULATION TO EXTEND TIME for Defendants POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer, or otherwise respond to the Complaint (D.I. 1) to March 21, 2024 - filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) (Entered: 02/20/2024) (2)
Feb 15, 2024 17 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Lantheus Holdings, Inc.; Corporate Parent Lantheus Holdings, Inc. for Lantheus Medical Imaging, Inc. filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Wilson, Samantha) (Entered: 02/15/2024) (3)
Feb 15, 2024 N/A SO ORDERED re 16 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. to move against, answer, or otherwise respond to the Complaint to March 21, 2024 (Set/Reset Answer Deadlines: Lantheus Holdings, Inc. answer due 3/21/2024; Lantheus Medical Imaging, Inc. answer due 3/21/2024). ORDERED by Judge Maryellen Noreika on 2/15/2024. (dlw) (Entered: 02/15/2024) (0)
Feb 15, 2024 16 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. to move against, answer, or otherwise respond to the Complaint to March 21, 2024 - filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Gaza, Anne) (Entered: 02/15/2024) (2)
Feb 9, 2024 N/A Pro Hac Vice Attorneys John C. Rozendaal, Dennies Varughese, and Alexander V. Alfano for Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/09/2024) (0)
Feb 9, 2024 N/A Pro Hac Vice Attorney Robert W. Trenchard for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/09/2024) (0)
Feb 9, 2024 N/A SO ORDERED re 14 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc. ORDERED by Judge Maryellen Noreika on 2/9/2024. (dlw) (Entered: 02/09/2024) (0)
Feb 8, 2024 15 Pro Hac Vice Fee - Credit Card Payment received for Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano. ( re 14 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano )( Payment of $ 150, receipt number ADEDC-4334186).(Gaza, Anne) (Entered: 02/08/2024) (0)
Feb 8, 2024 14 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano - filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Gaza, Anne) (Entered: 02/08/2024) (6)
Feb 6, 2024 N/A Pro Hac Vice Attorney Katherine M. Worden for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/06/2024) (0)
Feb 6, 2024 N/A Pro Hac Vice Attorney Andrew P. Blythe for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/06/2024) (0)
Feb 5, 2024 N/A SO ORDERED re 12 MOTION for Pro Hac Vice Appearance of Attorney Katherine Worden filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. ORDERED by Judge Maryellen Noreika on 2/5/2024. (dlw) (Entered: 02/05/2024) (0)
Feb 5, 2024 13 Pro Hac Vice Fee - Credit Card Payment received for Katherine Worden. ( re 12 MOTION for Pro Hac Vice Appearance of Attorney Katherine Worden )( Payment of $ 50, receipt number ADEDC-4330470).(Silver, Daniel) (Entered: 02/05/2024) (0)
Feb 5, 2024 12 MOTION for Pro Hac Vice Appearance of Attorney Katherine Worden - filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Attachments: # 1 Certification for Katherine Worden)(Silver, Daniel) (Entered: 02/05/2024) (0)
Feb 2, 2024 N/A SO ORDERED re 10 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. ORDERED by Judge Maryellen Noreika on 2/2/2024. (dlw) (Entered: 02/02/2024) (0)
Feb 1, 2024 11 Pro Hac Vice Fee - Credit Card Payment received for Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe. ( re 10 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe )( Payment of $ 150, receipt number ADEDC-4328535).(Silver, Daniel) (Entered: 02/01/2024) (0)
Feb 1, 2024 10 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe - filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Silver, Daniel) (Entered: 02/01/2024) (5)
Jan 31, 2024 N/A Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 01/31/2024) (0)
Jan 30, 2024 9 SUMMONS Returned Executed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA.Point Biopharma Global Inc. served on 1/29/2024, answer due 2/20/2024. (Silver, Daniel) (Entered: 01/30/2024) (2)
Jan 30, 2024 8 SUMMONS Returned Executed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA.Point Biopharma USA Inc. served on 1/29/2024, answer due 2/20/2024. (Silver, Daniel) (Entered: 01/30/2024) (2)
Jan 26, 2024 7 DECLARATION of Service of Complaint and related papers on Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. (Silver, Daniel) Modified on 1/31/2024 (dlw). (Entered: 01/26/2024) (2)
Jan 25, 2024 6 Summons Issued as to Lantheus Holdings, Inc. on 1/25/2024; Lantheus Medical Imaging, Inc. on 1/25/2024; Point Biopharma Global Inc. on 1/25/2024; Point Biopharma USA Inc. on 1/25/2024. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued) (vfm) (Entered: 01/25/2024) (0)
Jan 25, 2024 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (vfm) (Entered: 01/25/2024) (2)
Jan 25, 2024 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,596,276. (vfm) (Entered: 01/25/2024) (1)
Jan 25, 2024 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/12/2023. Date of Expiration of Patent: 07/25/2038.Thirty Month Stay Deadline: 6/12/2026. (vfm) (Entered: 01/25/2024) (2)
Jan 25, 2024 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 01/25/2024) (3)
Jan 25, 2024 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc., Point Biopharma Global Inc., Point Biopharma USA Inc. ( Filing fee $ 405, receipt number ADEDC-4322133.) - filed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (vfm) (Entered: 01/25/2024) (0)
Menu